EP0406734A2 — 2-(Aminoaryl)indoles and indolines, a process for their preparation and their use as medicaments
Assigned to Aventis Pharmaceuticals Inc · Expires 1991-01-09 · 35y expired
What this patent protects
There are described compounds of the formula where A is CH or N; X is hydrogen, loweralkyl, halogen, trifluromethyl, loweralkoxy, arylloweralkoxy, hydroxy or phenylamino; Y is hydrogen, loweralkyl, halogen, loweralkoxy, arylloweralkoxy or hydroxy; R 1 is hydrogen…
USPTO Abstract
There are described compounds of the formula where A is CH or N; X is hydrogen, loweralkyl, halogen, trifluromethyl, loweralkoxy, arylloweralkoxy, hydroxy or phenylamino; Y is hydrogen, loweralkyl, halogen, loweralkoxy, arylloweralkoxy or hydroxy; R 1 is hydrogen or loweralkyl; R 2 is hydrogen, loweralkyl, formyl, alkylcarbonyl, arylloweralkylcarbonyl, arylcarbonyl, alkoxycarbonyl, arylloweralkoxycarbonyl or aryloxycarbonyl; R 3 is hydrogen, alkyl, alkylcarbonyl, arylloweralkylcarbonyl, arylcarbonyl, alkoxycarbonyl, arylloweralkoxycarbonyl, aryloxycarbonyl or -CH 2 CO 2 C 2 H 5 ; which compounds are useful as topical antiinflammatory agents for the treatment of skin disorders, and a process for their preparation.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.